Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 7 , Pages 1417-1425 , July 2008

Off-Label Use of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) for Reconstruction of Mandibular Bone Defects in Humans

  • Todd G. Carter, DMD

      Affiliations

    • Private Practice, Wailuku, HI; and Formerly, Chief Resident, University of Washington, Department of Oral and Maxillofacial Surgery, Seattle, WA.
  • ,
  • Pardeep S. Brar, DMD

      Affiliations

    • Chief Resident, University of Washington, Department of Oral and Maxillofacial Surgery, Seattle, WA.
  • ,
  • Andrew Tolas, DDS

      Affiliations

    • Private Practice, Kent, WA; and Clinical Associate Professor, University of Washington, Department of Oral and Maxillofacial Surgery, Seattle, WA.
  • ,
  • O. Ross Beirne, DMD, PhD

      Affiliations

    • Professor and Chair, University of Washington, Department of Oral and Maxillofacial Surgery, Seattle, WA.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Beirne: University of Washington, Department of Oral and Maxillofacial Surgery, Box 357134, Seattle, WA 98195-7134

References 

  1. Ahlmann E, Patzakis M, Roidis N, et al. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am. 2002;84A:716
  2. Heary RF, Schlenk RP, Sacchieri TA, et al. Persistent iliac crest donor site pain: Independent outcome assessment. Neurosurgery. 2002;50:510
  3. Kalk WWI, Raghoebar GM, Jansma J, et al. Morbidity from iliac crest bone harvesting. J Oral Maxillofac Surg. 1996;54:1424
  4. Beirne OR. Comparison of complications after bone removal from lateral and medial plates of the anterior ilium for mandibular augmentation. Int J Oral Maxillofac Surg. 1986;15:269
  5. Marx RE, Morales MJ. Morbidity from bone harvest in major jaw reconstruction: A randomized trial comparing the lateral anterior and posterior approaches to the ilium. J Oral Maxillofac Surg. 1988;46:196
  6. Tayapongsak P, Wimsatt JA, LaBanc JP, et al. Morbidity from anterior ilium bone harvest (A comparative study of lateral versus medial surgical approach). Oral Surg Oral Med Oral Pathol. 1994;78:296
  7. Toriumi DM, Kotler HS, Luxenberg DP, et al. Mandibular reconstruction with a recombinant bone inducing factor. Arch Otolaryngol Head Neck Surg. 1991;117:1101
  8. Boyne P. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg Am. 2001;83A:S146
  9. Seto I, Asabina I, Oda M, et al. Reconstruction of the primate mandible with a combination graft of recombinant human bone morphogenetic protein-2 and bone marrow. J Oral Maxillofac Surg. 2001;59:53
  10. Moghadam HG, Urist T, Sandor GK, et al. Successful mandibular reconstruction using a BMP bio-implant. J Craniofac Surg. 2001;12:119
  11. Terheyden H, Knak C, Jepsen S, et al. Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: An experimental study in miniature pigs (Part I: Prefabrication). Int J Oral Maxillofac Surg. 2001;30:373
  12. Terheyden H, Warnke P, Dunsche A, et al. Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: An experimental study in miniature pigs (Part II: Transplantation). Int J Oral Maxillofac Surg. 2001;30:469
  13. Warnke PH, Springer IN, Wiltfang J, et al. Growth and transplantation of a custom vascularized bone graft in a man. Lancet. 2004;364:766
  14. Urist MR, Granstein R, Nogami H, et al. Transmembrane bone morphogenesis across multiple walled diffusion chambers. Arch Surg. 1977;122:612
  15. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science. 1988;242:1528
  16. 2.1 Physician labeling (3/8/2007) Infuse bone graft for certain oral maxillofacial and dental regenerative uses (Important medical information, Rx only). http://www.fda.gov/cdrh/pdf5/p050053c.pdfAccessed December 18, 2007
  17. Chin M, Ng T, Tom W, et al. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Craniofac Surg. 2005;16:778
  18. Herford AS, Boyne PJ, Williams RP. Clinical applications of rhBMP-2 in maxillofacial surgery. J Calif Dent Assoc. 2007;35:335
  19. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior spine. Spine. 2006;31:2813
  20. Nakahara H, Takaoka K, Koezuka M, et al. Periosteal bone formation elicited by partially purified bone morphogenetic protein. Clin Orthop. 1989;239:299
  21. King GN, Cochran DL. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: A critical review. J Periodontol. 2002;73:925
  22. Pang EK, Im SU, Kim CS, et al. Effects of recombinant human bone morphogenetic protein-4 dose on bone formation in rat calvarial defects. J Periodontol. 2004;75:1364
  23. Kim CS, Kim JI, Kim J, et al. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate carriers. Biomaterial. 2005;26:2501
  24. Boden SD. ABC's of BMPs. Orthop Nurs. 2005;24:49

PII: S0278-2391(08)00223-1

doi: 10.1016/j.joms.2008.01.058

Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 7 , Pages 1417-1425 , July 2008